|
Market Closed -
Nasdaq
21:00:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.900 USD | +3.72% |
|
+11.43% | -31.22% |
| 11-06 | MannKind Likely Offering Favorable Demand Trends, RBC Says | MT |
| 11-06 | RBC Raises Price Target on MannKind to $5 From $4.75, Keeps Sector Perform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.25B | - | - | - | ||
| 65.94B | |||||
| 56.53B | |||||
| 56.88B | |||||
| 46.49B | |||||
| 44.8B |
- Stock Market
- Stocks
- MNKD Stock
- Charts MannKind Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
